22nd Century Group, Inc. (XXII) Starts Presentation at LD Micro Conference

22nd Century Group, Inc. is a plant biotechnology company whose proprietary technology utilizes genetic engineering and plant breeding to decrease or increase the levels of nicotine and other nicotinic alkaloids, as well as decrease or increase levels of cannabinoids in the cannabis plant. The company has a robust patent portfolio consisting of numerous exclusive licenses, pending patent applications, and co-exclusive rights. Goodrich Tobacco focuses on commercial tobacco products and potentially less harmful cigarettes. Botanical Genetics focuses on novel cannabis plant varieties and on cannabis-based products. Hercules Pharmaceuticals focuses on X-22, a prescription smoking cessation aid in development. For more information, visit the company’s website at www.xxiicentury.com.